Our Department Mission....Delivering Excellence and Trust in Pharmaceutical Care through a Culture of Precision.

HIGH ALERT: Please read the COMMENTS very carefully.

Search results for:

ENOXAPARIN

ENOXAPARIN
Drug Name Form Strength Non-Formulary Notes
LOVENOX INJECTION 30MG/0.3ML  
LOVENOX INJECTION 40 MG/0.4 ML  
LOVENOX INJECTION 60 MG/0.6 ML  
LOVENOX INJECTION 80 MG/0.8 ML  
LOVENOX INJECTION 80 MG/0.8 ML  
LOVENOX INJECTION 100 mg/ml  
LOVENOX INJECTION 120 MG/0.8 ML  
LOVENOX INJECTION 150 mg/ml  

View Other Therapeutic Options: Antithrombotic Agents, Heparins: 201200, 20120416
High Alert Drug

Comments:

Renal dosing removed temporarily, refer to Renal Dosing Policy via Policy Finder on GHS Connect

LMWH Anti-Xa Dose Adjustment Policy

Weight-Based Dosing Policy

Enoxaparin Dose Rounding

Low Molecular Weight Heparins: Drug Safety Communication - Recommendations to Decrease Risk of Spinal Column Bleeding and Paralysis

Reversal of Anticoagulants

Anticoagulation Alerts Chart

 

 The High Risk/High Alert Medication Policy may be found by using the search function in Policies and Procedures.

 The Anticoagulation Management Program may be found by using the search function in Policies and Procedures.


Last updated: Apr. 22, 2023


This site is intended for the staff of Genesis Health System.
While others may view accessible pages, Genesis Health System makes no warranty, express or implied,
as to the use of this information outside of Genesis Health System.